These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2150471)

  • 1. [Current physiopathological concerns in arterial hypertension].
    Pannier BM; London GM; Laurent S; Safar ME
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():23-5. PubMed ID: 2150471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac hypertrophy and aortic distensibility in essential hypertension.
    Safar ME; Laurent S; Asmar RA; Hugue CJ; London GM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S86-90. PubMed ID: 2485034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiopathology of arterial hypertension. Significance of the renin-angiotensin-aldosterone system and structural changes].
    Fernandes A
    Rev Port Cardiol; 1989 Apr; 8(4):275-80. PubMed ID: 2534357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brachial arterial pressure to assess cardiovascular structural damage: an overview and lessons from clinical trials.
    London GM
    J Nephrol; 2008; 21(1):23-31. PubMed ID: 18264933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of arterial pulse and reflective waves on systolic blood pressure and cardiac function.
    London GM; Guérin A
    J Hypertens Suppl; 1999 Jun; 17(2):S3-6. PubMed ID: 10465060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium inhibitors and arterial hypertension].
    Hugue C; Safar M
    J Mal Vasc; 1989; 14(4):356-9. PubMed ID: 2685164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible impact of arterial compliance on cardiac hypertrophy in arterial hypertension.
    Pannier BM; London GM; Safar ME
    Scand J Clin Lab Invest Suppl; 1989; 196():22-7. PubMed ID: 2530618
    [No Abstract]   [Full Text] [Related]  

  • 9. Interrelations of cardiac and arterial vascular wall hypertrophy in essential hypertension.
    Geri A; Agabiti-Rosei E; Muiesan ML; Romanelli G; Platto L; Muiesan G
    J Hypertens Suppl; 1985 Dec; 3(3):S335-7. PubMed ID: 2856732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of aortic distensibility and its variations in arterial hypertension.
    Torbova S; Sheiretova E; Belov Y
    Cor Vasa; 1981; 23(2):126-31. PubMed ID: 7249660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for cardiac involvement in essential hypertension.
    Zahka KG
    Cardiol Clin; 1986 Feb; 4(1):81-93. PubMed ID: 2939953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood pressure components and target organ damage].
    Schillaci G; Reboldi G; Vaudo G
    Ital Heart J Suppl; 2001 Apr; 2(4):363-8. PubMed ID: 19397008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertrophy of the arterial wall and arterial rigidity].
    Laurent S; Boutouyrie P
    Pathol Biol (Paris); 1999 Jun; 47(6):648-55. PubMed ID: 10472076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct monitoring pressure overload predicts cardiac hypertrophy in mice.
    Duan SZ; Ivashchenko CY; Whitesall SE; D'Alecy LG; Mortensen RM
    Physiol Meas; 2007 Nov; 28(11):1329-39. PubMed ID: 17978418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Temporal evolution of structural and functional parameters of cardiac hypertrophy induced in Wistar rats by abdominal aorta constriction].
    Bregagnollo EA; Rodrigues MA; Montenegro MR; Curi PR; Tucci PJ
    Arq Bras Cardiol; 1986 Jan; 46(1):9-17. PubMed ID: 2949727
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.
    Nichols WW
    Am J Hypertens; 2005 Jan; 18(1 Pt 2):3S-10S. PubMed ID: 15683725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment.
    Safar ME; Toto-Moukouo JJ; Bouthier JA; Asmar RE; Levenson JA; Simon AC; London GM
    Circulation; 1987 Jan; 75(1 Pt 2):I156-61. PubMed ID: 2947747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for benefits of perindopril in hypertension and its complications.
    Laurent S
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):155S-162S. PubMed ID: 16125052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Left ventricular hypertrophy in hypertension: functional aspects].
    Lombardo M; Zaini G; Colloca W; Belli C
    G Ital Cardiol; 1987 Dec; 17(12):1039-44. PubMed ID: 2972580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective and prospective research on hypertension-related end-organ damage.
    Perloff D
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S1-5. PubMed ID: 7603071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.